Monthly-Stock-Portfolio-Elite-Wealth

Monthly-Stock-Portfolio-elite

Company Recommendation Accu./Buy(Rs) Target (Rs) Upside

(%)

Time Horizon
Dr. Reddy’s Laboratories Buy 4556 4775 5% 1Month
ICICI Bank Buy 903 1050 16% 1Month
Infosys Buy 1550.70 1720 11% 1Month
ITC Buy 352.50 383 9% 1Month
L&T Infotech Buy 4860.70 5500 13% 1Month
Maruti Suzuki Accumulate 9220-8900 9800 10% 1Month
Tata Chemicals Buy 1135 1400 23% 1Month
TCS Buy 3240 3800 17% 1Month
Reliance Industries Buy 2545 2800 10% 1Month
Siemens Buy 2906 3300 13.5% 1Month
 Consider the prices as on 3rd  November 2022 at 10 am
Weightage of Investment (Rs.10 Lakh)
Company Amount (Rs) Weightage (%)
Dr. Reddy’s Laboratories 1,00,000 10%
ICICI Bank 1,00,000 10%
Infosys 80,000 8%
ITC 80,000 8%
L&T Infotech 80,000 8%
Maruti Suzuki 80,000 8%
Tata Chemicals 1,00,000 10%
TCS 1,00,000 10%
Reliance Industries 13,00,000 13%
Siemens 12,00,000 12%
Cash 30,000 3%
Total 10,00,000 100%

Dr. Reddy’s Laboraories Ltd.:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
4556 DRREDDY/500124 75,586.58 Pharmaceuticals 83.2 5.00 1247.78 0.54

Dr. Reddy’s Laboratories Ltd. is engaged in Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. The company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (“APIs”), Custom Pharmaceutical Services (“CPS”), generics, biosimilars and differentiated formulations. The company delivered better than street expected results for Q2FY23 because of 48% growth in US business and g-Revlimid drug launch. Total Revenue of the company increased 9.4% YoY to Rs 6,305.7 crore and Net profit grew by 12% YoY to Rs 1,114.2 crore in the September 2022 quarter. Operating profit margin for the Q2FY23 rose by 340 bps YoY to 31%. Company spent 7.7% out of total revenue on the Research and Development for the same quarter.

ICICI Bank Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
903 ICICIBANK/532174 6,33,424 Private Bank 1394.13 2.00 274.58 1.03

ICICI Bank Ltd. is a publicly held banking company engaged in providing a wide range of banking and financial services including commercial banking and treasury operations. The bank delivered great performance in September quarter of FY23. On consolidated front, the bank has reported 31.4% YoY growth in the Net Profit to Rs 8,007 crore for the quarter ended September 2022, up from Rs 6,092 crore in the same quarter previous year. Net Interest Income increased 26.5% yearly to Rs 14,787 crore, while other income moved up 16.8% YoY to Rs 5,139 crore. The operating profit improved 23.6% to Rs 11,765 crore in the quarter ended September 2022. Net Interest Margin grew to 4.31% (QoQ) in Q2FY23 from 4.01% in Q1FY23. For the September quarter CASA ratio of the bank stood at 46.6% and Net NPA ratio declined to 0.61% from 0.70% at June 30, 2022.

Infosys Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
1553 INFY/ 500209 6,61,786 IT-Software 2103.91 5.00 170.27 1.02

Infosys Ltd. is engaged to provide consulting, technology, outsourcing and next-generation digital services, to enable clients to execute strategies for their digital transformation. Its key services include application development, product co-development and system implementation/system engineering. The company shown growth across verticals; Sequential currency growth stood at 4% and large deals remain strong at $2.7 billion in the September quarter, growth of 28% YoY. Net Profit of Infosys grew 12.3% QoQ and Ebit margin grew by 150 bps QoQ at 21.5% for the same quarter. The company has increased revenue guidance to 15-16% from 14-16% for FY23.              

ITC Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
353 ITC/500875 4,33,391 Cigarettes 1240.39 1.00 52.91 0.67

ITC Ltd. is one of India’s foremost multi-business enterprises. Its diversified portfolio of businesses is spanning in FMCG, Paperboards & Packaging, Agri Business, Hotels and Information Technology. It delivered robust performance across all segments in the September 2022 quarter. Revenue of the company increased 25% to Rs 16,930 crore in the Q2FY23 and Net profit also rose to 24.4% (YoY) to Rs 4,620 crore in the quarter ended September, 2022. The company’s cigarette business grew by 23.3% to Rs 6954 crore during the quarter, while FMCG-others business, which includes packaged food and personal care products, grew 21% to Rs 4,885 crore; the segment’s EBITDA Sustained at 9.5%. ITC reported a healthy performance across segments. The Cigarettes business is gaining market share and is going to maintain volumes because of stable tax policies. Also foreign portfolio investors have been increasing their positions in ITC for the last four consequent quarters.

Larsen & Toubro Infotech Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
4860 LTI/ 540005 85,245 IT-Software 17.54 1.00 524.17 1.19

Larsen & Toubro Infotech Ltd. offers extensive range of IT services like application development, maintenance and outsourcing, enterprise solutions, infrastructure management services, testing, digital solutions and platform-based solutions to the clients in diverse industries. It showed strong financial performance in September 2022 quarter. Total Revenue of the company increased 28.4% to Rs 4,837 crore in the September 2022 quarter, up from Rs 3,767 crore in the September 2021 quarter and Net profit also grew by 23.2% (YoY) to Rs 679.3 crore in the same quarter. EBIT Margin improved by 10bps in the September quarter; Total contract value for the period rose to US$ 80 million and company signed 4 new large deals.

Maruti Suzuki Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
9200 MARUTI/ 532500 2,78,767 Automobile 151.04 5.00 1892.91 0.91

Maruti Suzuki India Ltd. is a subsidiary of Suzuki Motor Corporation, Japan. The principal activities of the Company are manufacturing, purchase and sale of motor vehicles, components and spare parts. The other activities of the Company comprise facilitation of pre-owned car sales, fleet management and car financing. The company delivered significant financial performance in the September quarter due to ease in semiconductor shortages and decline in commodity prices. Total revenue of the company rose to 28,546 crore up 48% YoY and Net profit also increase hugely by 334% to 2,113 crore for Q2FY23. New launch of Vitara and Brezza has received good response from the customers. Company’s plan to launch more vehicles in the CNG variant and focus on the SUVs would further drive the growth in the coming period.

Tata Chemicals Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
1135 TATACHEM/500770 28,863 Chemicals 254.8 10.00 753.29 1.14

 

Tata Chemicals Ltd. is one of the largest manufacturer of soda ash and sodium bicarbonate for diverse industries, such as glass, detergents, silicates, textiles, food, pharmaceuticals, animal feed, mining and chemical processing. The September quarter result of the company showed significant growth. It reported 40% increase in its consolidated net sales for the quarter ended September 2022 to Rs 4,239 crore compared to corresponding previous year period because of robust soda ash demand. Net profit of the company was up 184% to Rs 629 crore YoY; Specialty products sales grew 27% YoY for the same quarter.

Tata Consultancy Services Ltd.:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
3240 TCS/532540 79,184 IT-Software 365.91 1.00 265 0.83

Tata Consultancy Services Ltd. is one of the leading IT Company in the world which provide IT services, consulting and business solutions and have been partnering with many of the world’s largest businesses in their transformation journeys. The Group offers a consulting-led, cognitive powered, integrated portfolio of IT, business and engineering services and solutions. The company delivered above estimates results in the September quarter. Revenue and Net profit of the company grew 18% and 8.4% yearly to Rs 55,309 crore and 10,431 crore respectively in the September quarter. EBIT margin increased by 94 basis points to 24%. It showed double digit growth in all segments, North-America business continues to be growth driver for the company. The Total Contract Value grew 6.6% YoY and stood at US$ 8.1 billion. TCS continue to make investments in research and innovation and remains with rich cash flow.

Reliance Industries Ltd:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
2545 RELIANCE/500325 17,22,058 Refineries 6765.4 10.00 1167.78 1.08

Reliance Industries Ltd. is one of India’s largest multinational conglomerate company engaged in activities spanning across hydrocarbon exploration and production, Oil to chemicals, retail, digital services and financial services. It delivered strong financial performance across segments. Consolidated revenue of the company rose 37% YoY to Rs. 2,30,055 crore in the September 2022 quarter compared to 1,67,611 crore in the previous year same quarter. Retail segment continue to scale, segment revenue grew 43% YoY and total store count crossed 16,000 mark, Digital services revenue growth was at 21% YoY; showed strong data traffic growth. Oil to Chemicals business revenue increased by 33% YoY. Overall growth across segments looks promising.

Siemens Ltd.:

CMP NSE/BSE Symbol MCAP (Cr) Sector Equity (Cr) Face Value Book Value Beta-Sensex
2904 SIEMENS/500550 1,03,558 Capital Goods – Electrical Equipment 71.22 2.00 298.43 0.86

Siemens Ltd. is engaged to offer products, integrated solutions for industrial applications for manufacturing industries, drives for process industries, intelligent infrastructure and buildings, efficient and clean power generation from fossil fuels and oil & gas applications, transmission and distribution of electrical energy for passenger and freight transportation, including rail vehicles, rail automation and rail electrification. The company delivered strong performance despite challenging environment in Q1FY23. Total sales rose 50.5% to Rs 4,198 crore in the June 2022 quarter, up from Rs 2,789 crore in the June 2021 quarter. Its Net profit grew significantly by 112% YoY to Rs 300.7 crore in the quarter ended June, 2022. Siemens is aiming to target the SME segment, which will allow it to scale up, adopt new designs & components and stay competitive.

 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL